Drug Profile
Pefcalcitol - Maruho
Alternative Names: CLS 008; M-5180; M-518101Latest Information Update: 28 Apr 2023
Price :
$50
*
At a glance
- Originator Maruho
- Class Acetamides; Anti-inflammatories; Fluorocarbons; Indenes; Skin disorder therapies; Small molecules; Vitamin D analogues
- Mechanism of Action Phosphoric diester hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase III Palmoplantar keratoderma; Plaque psoriasis
- Discontinued Warts
Most Recent Events
- 18 Apr 2023 Maruho withdraws a phase II trial in Plaque psoriasis (In adolescents) in USA (Topical) prior to enrollment as per US FDA's request (NCT02970331)
- 30 Nov 2022 Discontinued - Phase-II for Warts in Japan (Topical)
- 30 Nov 2022 Discontinued - Preregistration for Plaque psoriasis in USA (Topical)